GZMK

protein-coding

granzyme K, the group of Granule associated serine proteases of immune defence

Gene summary

This gene product is a member of a group of related serine proteases from the cytoplasmic granules of cytotoxic lymphocytes. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein described here lacks consensus sequences for N-glycosylation present in other granzymes. [provided by RefSeq, Jul 2008]

MANE transcript

NM_002104.3

Inheritance

—

ClinVar variants

U:35B:7

Top phenotype

—

gnomAD constraint

pLI —, LoF o/e 0.46

Max pathogenic AF

—

Genomic locus

chr5:55,024,256-55,034,570

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~10.3 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

No GenCC data available for this gene.

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to GZMK variants in ClinVar

1 Conditions Cataloged
not specifiedTotal: 38

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_002104.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
0
missense
35
clinvar
7
clinvar
42
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total00357042
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 3 of 3 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_002104.3RefSeqNP_002095.15MANE Select
ENST00000231009.3EnsemblENSP00000231009.25MANE Select
ENST00001090631.1EnsemblENSP00000760437.12Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • proteolysis

Molecular Function

  • serine-type endopeptidase activity
  • serine-type peptidase activity

Cellular Component

  • extracellular region

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000231009
Coding exons
5
Length
10318
Individuals with no LoFs
125673
Homozygous LoFs
0
Heterozygous LoFs
72
Defined
125745
p
0.000286
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.3181321430.9250.000007061701
Missense (PolyPhen)5858.340.99416682
Synonymous-0.3215754.01.060.00000293528
Loss of Function1.66510.90.4586.09e-7129

Population LoF Frequency

PopulationCAFp-valueStatus
African0.00210.0021notable
Latino/Admixed American0.000850.00084rare
Ashkenazi Jewish0.0000990.000099rare
East Asian0.000110.00011rare
Finnish00.0absent
European (Non-Finnish)0.0000350.000035rare
South Asian0.0000660.000065rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Intolerance Scores

LoFtool
0.303
RVIS EVS
-0.27
RVIS percentile EVS
34.6

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.0788

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.